Literature DB >> 9712357

Validation of haplotype frequency estimation methods.

R F Schipper1, J D'Amaro, P de Lange, G M Schreuder, J J van Rood, M Oudshoorn.   

Abstract

In order to investigate the performance of haplotype frequency estimation methods using unrelated individuals, we compared the results of three estimation methods with those from the haplotypes deduced from family pedigrees. To that end we used the HLA phenotypes of the parents of 1040 families as data for the estimation methods and the full pedigree information as data for the deductive method. We evaluated the results of the following estimation methods: the method using two by two tables described by Mattiuz et al., the maximum likelihood method described by Yasuda and Tsuji and a crude method that uses the information on homozygosity in the phenotypes. All estimation methods generate reliable haplotype frequencies for the more frequent haplotypes, but are unreliable for the less frequent haplotypes. The maximum likelihood estimation method shows the best overall correlation with the results of the deductive method.

Mesh:

Substances:

Year:  1998        PMID: 9712357     DOI: 10.1016/s0198-8859(98)00054-8

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  4 in total

1.  Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.

Authors:  D Fallin; A Cohen; L Essioux; I Chumakov; M Blumenfeld; D Cohen; N J Schork
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

2.  Methods for assessing gene content diversity of KIR with examples from a global set of populations.

Authors:  Richard M Single; Maureen P Martin; Diogo Meyer; Xiaojiang Gao; Mary Carrington
Journal:  Immunogenetics       Date:  2008-09-17       Impact factor: 2.846

3.  The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.

Authors:  Jill Rubin; Han Jo Kim; Thomas A Pearson; Steve Holleran; Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Atherosclerosis       Date:  2008-03-04       Impact factor: 5.162

4.  Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients.

Authors:  Gunnar Wichmann; Claudia Lehmann; Cindy Herchenhahn; Marlen Kolb; Mathias Hofer; Susanne Wiegand; Andreas Dietz
Journal:  Front Oncol       Date:  2018-05-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.